CV Sciences (CVSI) Notes Payables (2011 - 2022)
CV Sciences (CVSI) reported Notes Payables of $952000.0 for Q2 2022, down 68.25% on a YoY basis from $3.0 million in Q2 2021, and down 8.11% sequentially from $1.0 million in Q1 2022.
CV Sciences (CVSI) Notes Payables (2011 - 2022) Analysis & Trends
CV Sciences (CVSI) has 11 years of Notes Payables data on file, last reported at $952000.0 in Q2 2022.
- For the quarter ending Q2 2022, Notes Payables fell 68.25% year-over-year to $952000.0; the trailing twelve-month figure through Jun 2022 stood at $952000.0 (down 68.25% YoY), and the FY2021 full-year result was $612000.0, changed N/A from the prior year.
- Notes Payables slipped to $952000.0 in Q2 2022, from $1.0 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $3.0 million in Q2 2021 to a low of $66883.0 in Q1 2018.
- A 5-year average of $965245.5 and a median of $612000.0 in 2021 frame the typical range for Notes Payables.
- Across the five-year window, Notes Payables soared 5998.77% in 2018 and slumped 92.04% in 2019, its largest moves.
- Tracing CVSI's Notes Payables over 5 years: stood at $474000.0 in 2018, then sank by 85.44% to $69000.0 in 2019, then soared by 426.09% to $363000.0 in 2020, then soared by 68.6% to $612000.0 in 2021, then surged by 55.56% to $952000.0 in 2022.
- Business Quant data shows CVSI's Notes Payables at $952000.0 in Q2 2022, $1.0 million in Q1 2022, and $612000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 952,000.00 |
| Mar 31, 2022 | 1.04 Mn |
| Dec 31, 2021 | 612,000.00 |
| Jun 30, 2021 | 3.00 Mn |
| Mar 31, 2021 | 2.91 Mn |
| Sep 30, 2020 | 363,000.00 |
| Jun 30, 2019 | 69,000.00 |
| Mar 31, 2019 | 273,000.00 |
| Dec 31, 2018 | 474,000.00 |
| Jun 30, 2018 | 866,818.00 |
| Mar 31, 2018 | 66,883.00 |
| Dec 31, 2017 | 726,000.00 |
| Sep 30, 2017 | 3,225.00 |
| Jun 30, 2017 | 14,213.00 |
| Mar 31, 2017 | 41,500.00 |
| Dec 31, 2016 | 222,800.00 |
| Jun 30, 2016 | 20,065.00 |
| Sep 30, 2015 | 1.48 Mn |
| Jun 30, 2015 | 769,645.00 |
| Dec 31, 2013 | 300.00 |